Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

lilly cover image
$599
Posted in: Basal Insulin, Dual/triple agonist, Insulin Delivery, Other Aug 04 | 2022Mounjaro Off to an Impressive Start; Lilly Q2 ’22 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, Glucose Monitoring, Other Jul 29 | 2022Dexcom G7 Delayed in US; Dexcom, Pfizer, Biocon, Sanofi, and Teladoc Q2 ’22 Earnings UpdatesPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Insulin Delivery Jul 22 | 2022Tandem Acquires Capillary Biomedical; Lilly’s Mounjaro Receives Positive CHMP OpinionPurchase Blast
lilly cover image
$599
Posted in: Dual/triple agonist Jul 13 | 2022Lilly to Initiate GGG Ph1 DDI StudyPurchase Blast
1 2 3 69

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.